Bin1 attenuation in breast cancer is correlated to nodal metastasis and reduced survival

Arezoo Ghaneie, Vlasta Zemba-Palko, Hiromichi Itoh, Kaori Itoh, Daitoku Sakamuro, Seigo Nakamura, Alejandro Peralta Soler, George C. Prendergast

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Clinical outcomes in breast cancer are likely influenced by modifier genes that affect tumor dormancy versus progression. The Bin1 gene encodes a nucleocytosolic adapter protein that suppresses neoplastic cell transformation and that is often attenuated in human breast carcinoma. Recent mouse genetic studies indicate that Bin1 loss cooperates with ras activation to drive progression of mammary carcinoma, establishing Bin1 as a negative modifier of tumor progression in breast cancer. In this study, we investigated whether immunohistochemical losses of nuclear Bin1 proteins in cases of human breast cancer were correlated to progression status. In American and Japanese groups of low or middle grade breast cancers, losses were associated with reduced survival and increased nodal metastasis, respectively. Taken together with recent findings from mouse genetic studies, these findings encourage further evaluation of the potential utility of Bin1 as a clinical prognostic marker in breast cancer.

Original languageEnglish (US)
Pages (from-to)192-194
Number of pages3
JournalCancer Biology and Therapy
Volume6
Issue number2
DOIs
StatePublished - Jan 1 2007
Externally publishedYes

Fingerprint

Breast Neoplasms
Neoplasm Metastasis
Survival
Neoplastic Cell Transformation
Modifier Genes
Nuclear Proteins
Neoplasms
Biomarkers
Genes
Proteins

Keywords

  • Amphiphysin II
  • Breast cancer
  • Myc
  • Ras

ASJC Scopus subject areas

  • Molecular Medicine
  • Oncology
  • Pharmacology
  • Cancer Research

Cite this

Ghaneie, A., Zemba-Palko, V., Itoh, H., Itoh, K., Sakamuro, D., Nakamura, S., ... Prendergast, G. C. (2007). Bin1 attenuation in breast cancer is correlated to nodal metastasis and reduced survival. Cancer Biology and Therapy, 6(2), 192-194. https://doi.org/10.4161/cbt.6.2.3587

Bin1 attenuation in breast cancer is correlated to nodal metastasis and reduced survival. / Ghaneie, Arezoo; Zemba-Palko, Vlasta; Itoh, Hiromichi; Itoh, Kaori; Sakamuro, Daitoku; Nakamura, Seigo; Soler, Alejandro Peralta; Prendergast, George C.

In: Cancer Biology and Therapy, Vol. 6, No. 2, 01.01.2007, p. 192-194.

Research output: Contribution to journalArticle

Ghaneie, A, Zemba-Palko, V, Itoh, H, Itoh, K, Sakamuro, D, Nakamura, S, Soler, AP & Prendergast, GC 2007, 'Bin1 attenuation in breast cancer is correlated to nodal metastasis and reduced survival', Cancer Biology and Therapy, vol. 6, no. 2, pp. 192-194. https://doi.org/10.4161/cbt.6.2.3587
Ghaneie, Arezoo ; Zemba-Palko, Vlasta ; Itoh, Hiromichi ; Itoh, Kaori ; Sakamuro, Daitoku ; Nakamura, Seigo ; Soler, Alejandro Peralta ; Prendergast, George C. / Bin1 attenuation in breast cancer is correlated to nodal metastasis and reduced survival. In: Cancer Biology and Therapy. 2007 ; Vol. 6, No. 2. pp. 192-194.
@article{e4aca794a0d24ee38b5ca80d0a631c0c,
title = "Bin1 attenuation in breast cancer is correlated to nodal metastasis and reduced survival",
abstract = "Clinical outcomes in breast cancer are likely influenced by modifier genes that affect tumor dormancy versus progression. The Bin1 gene encodes a nucleocytosolic adapter protein that suppresses neoplastic cell transformation and that is often attenuated in human breast carcinoma. Recent mouse genetic studies indicate that Bin1 loss cooperates with ras activation to drive progression of mammary carcinoma, establishing Bin1 as a negative modifier of tumor progression in breast cancer. In this study, we investigated whether immunohistochemical losses of nuclear Bin1 proteins in cases of human breast cancer were correlated to progression status. In American and Japanese groups of low or middle grade breast cancers, losses were associated with reduced survival and increased nodal metastasis, respectively. Taken together with recent findings from mouse genetic studies, these findings encourage further evaluation of the potential utility of Bin1 as a clinical prognostic marker in breast cancer.",
keywords = "Amphiphysin II, Breast cancer, Myc, Ras",
author = "Arezoo Ghaneie and Vlasta Zemba-Palko and Hiromichi Itoh and Kaori Itoh and Daitoku Sakamuro and Seigo Nakamura and Soler, {Alejandro Peralta} and Prendergast, {George C.}",
year = "2007",
month = "1",
day = "1",
doi = "10.4161/cbt.6.2.3587",
language = "English (US)",
volume = "6",
pages = "192--194",
journal = "Cancer Biology and Therapy",
issn = "1538-4047",
publisher = "Landes Bioscience",
number = "2",

}

TY - JOUR

T1 - Bin1 attenuation in breast cancer is correlated to nodal metastasis and reduced survival

AU - Ghaneie, Arezoo

AU - Zemba-Palko, Vlasta

AU - Itoh, Hiromichi

AU - Itoh, Kaori

AU - Sakamuro, Daitoku

AU - Nakamura, Seigo

AU - Soler, Alejandro Peralta

AU - Prendergast, George C.

PY - 2007/1/1

Y1 - 2007/1/1

N2 - Clinical outcomes in breast cancer are likely influenced by modifier genes that affect tumor dormancy versus progression. The Bin1 gene encodes a nucleocytosolic adapter protein that suppresses neoplastic cell transformation and that is often attenuated in human breast carcinoma. Recent mouse genetic studies indicate that Bin1 loss cooperates with ras activation to drive progression of mammary carcinoma, establishing Bin1 as a negative modifier of tumor progression in breast cancer. In this study, we investigated whether immunohistochemical losses of nuclear Bin1 proteins in cases of human breast cancer were correlated to progression status. In American and Japanese groups of low or middle grade breast cancers, losses were associated with reduced survival and increased nodal metastasis, respectively. Taken together with recent findings from mouse genetic studies, these findings encourage further evaluation of the potential utility of Bin1 as a clinical prognostic marker in breast cancer.

AB - Clinical outcomes in breast cancer are likely influenced by modifier genes that affect tumor dormancy versus progression. The Bin1 gene encodes a nucleocytosolic adapter protein that suppresses neoplastic cell transformation and that is often attenuated in human breast carcinoma. Recent mouse genetic studies indicate that Bin1 loss cooperates with ras activation to drive progression of mammary carcinoma, establishing Bin1 as a negative modifier of tumor progression in breast cancer. In this study, we investigated whether immunohistochemical losses of nuclear Bin1 proteins in cases of human breast cancer were correlated to progression status. In American and Japanese groups of low or middle grade breast cancers, losses were associated with reduced survival and increased nodal metastasis, respectively. Taken together with recent findings from mouse genetic studies, these findings encourage further evaluation of the potential utility of Bin1 as a clinical prognostic marker in breast cancer.

KW - Amphiphysin II

KW - Breast cancer

KW - Myc

KW - Ras

UR - http://www.scopus.com/inward/record.url?scp=34247395824&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247395824&partnerID=8YFLogxK

U2 - 10.4161/cbt.6.2.3587

DO - 10.4161/cbt.6.2.3587

M3 - Article

VL - 6

SP - 192

EP - 194

JO - Cancer Biology and Therapy

JF - Cancer Biology and Therapy

SN - 1538-4047

IS - 2

ER -